CytoDyn Inc.
CYDY · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Market Cap | $408,630 | $154,540 | $218,919 | $230,146 |
| - Cash | $11,903 | $3,110 | $2,541 | $4,231 |
| + Debt | $27,341 | $30,076 | $35,414 | $36,797 |
| Enterprise Value | $424,068 | $181,506 | $251,792 | $262,712 |
| Revenue | -$5,916 | $0 | $0 | $266 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$18 | -$29 | -$175 | $213 |
| % Margin | 0.3% | – | – | 80.1% |
| EBITDA | $8,619 | -$18,029 | -$40,401 | -$194,973 |
| % Margin | -145.7% | – | – | -73,298.1% |
| Net Income | $3,745 | -$49,841 | -$79,824 | -$210,820 |
| % Margin | -63.3% | – | – | -79,255.6% |
| EPS Diluted | 0.002 | -0.053 | -0.095 | -0.43 |
| % Growth | 103.4% | 44.5% | 77.8% | – |
| Operating Cash Flow | -$8,765 | -$10,982 | -$25,110 | -$77,723 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$8,765 | -$10,982 | -$25,110 | -$77,723 |